B
Brian Skinnider
Researcher at University of British Columbia
Publications - 50
Citations - 2317
Brian Skinnider is an academic researcher from University of British Columbia. The author has contributed to research in topics: Lymphoma & ABVD. The author has an hindex of 20, co-authored 43 publications receiving 2070 citations. Previous affiliations of Brian Skinnider include BC Cancer Agency & Vancouver General Hospital.
Papers
More filters
Journal ArticleDOI
CHOP-R therapy overcomes the adverse prognostic influence of BCL-2 expression in diffuse large B-cell lymphoma
Kenneth S. Wilson,Laurie H. Sehn,Brian R. Berry,Mukesh Chhanabhai,Catherine Fitzgerald,Karamjit Gill,Richard Klasa,Brian Skinnider,Judy Sutherland,Joseph M. Connors,Randy D. Gascoyne +10 more
TL;DR: The addition of rituximab to CHOP chemotherapy negates the adverse prognostic influence of BCL-2 protein expression on progression free and overall survival in DLBCL.
Journal ArticleDOI
Early progression after bendamustine-rituximab is associated with high risk of transformation in advanced stage follicular lymphoma.
Ciara L. Freeman,Robert Kridel,Alden A. Moccia,Kerry J. Savage,Diego Villa,David W. Scott,Alina S. Gerrie,David J. P. Ferguson,Fergus Cafferty,Graham W. Slack,Pedro Farinha,Brian Skinnider,Joseph M. Connors,Laurie H. Sehn +13 more
TL;DR: Compared to a historical cohort treated with RCVP, EFS has improved and the risk of POD24 has decreased, but a higher proportion of patients with POD 24 harbor transformation, and the overall incidence of transformation appears unchanged.
Journal ArticleDOI
Expression analysis of kidney-specific cadherin in a wide spectrum of traditional and newly recognized renal epithelial neoplasms: diagnostic and histogenetic implications.
Adam Kuehn,Gladell P. Paner,Brian Skinnider,Cynthia Cohen,Milton W. Datta,Andrew N. Young,John R. Srigley,Mahul B. Amin +7 more
TL;DR: Ksp-cad is a useful tumor type associated marker for distinguishing chromophobe renal cell carcinoma and renal oncocytoma from the wide range of nonintercalated cell-related adult renal epithelial neoplasms; addition of this marker to a panel comprised of other histologic subtype-associated markers may greatly facilitate histologic subclassification of adult renal anatomy neoplasm.
Journal ArticleDOI
Follicular non-Hodgkin lymphoma grades 3A and 3B have a similar outcome and appear incurable with anthracycline-based therapy
J. Shustik,Margaret M. Quinn,Joseph M. Connors,Randy D. Gascoyne,Brian Skinnider,Laurie H. Sehn +5 more
TL;DR: Using strict diagnostic criteria, there appears to be no difference in outcome between patients with FL3A and FL3B and no evidence of curability with anthracycline-based therapy.
Journal ArticleDOI
Infarcted adenomatoid tumor: a report of five cases of a facet of a benign neoplasm that may cause diagnostic difficulty.
Brian Skinnider,Robert H. Young +1 more
TL;DR: Five cases in which adenomatoid tumors showed extensive necrosis, presumably due to infarction, and posed diagnostic difficulty are described, which may potentially lead to more aggressive therapy than warranted if it is not correctly interpreted.